Healthcare Stock on Trader’s Radar: Cronos Group Inc. (NASDAQ:CRON)

Shares of Cronos Group Inc. (NASDAQ:CRON) gained 11.73% to $23.25 on Thursday. The share price is trading in a range of 21.30 – 25.10 (Price in Dollars).

The stock exchanged hands 67.62M shares versus average trading capacity of 13.26M shares, while its shares’ total market worth is $4.16B. Cronos Group Inc. (NASDAQ:CRON) shares were trading 389.47% below from the 52-week high price mark of $389.47and +6.70% above from the 52-week price bottom of $4.75.

The company employs 103 people, over the last 12 months has generated revenue of $0.00 million and has a net income of $0.00 million.

The company’s EPS growth in prior 5 years was 0.00%. In the liquidity ratio analysis; current ratio was 0.00 while debt to equity ratio was 0.00.

Cronos Group (CRON) closed the most recent trading day at $18.15, moving -1.79% from the previous trading session. This change lagged the S&P 500’s 0.15% loss on the day. Elsewhere, the Dow gained 0.21%, while the tech-heavy Nasdaq lost 0.81%.

Heading into today, shares of the cannabis company had gained 77.86% over the past month, outpacing the Finance sector’s gain of 8.81% and the S&P 500’s gain of 6.55% in that time.

Investors will be hoping for strength from CRON as it approaches its next earnings release, which is expected to be April 29, 2019. The company is expected to report EPS of -$0.01, down 200% from the prior-year quarter. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $7.46 million, up 487.4% from the year-ago period.

Investors should also note any recent changes to analyst estimates for CRON. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, we can interpret positive estimate revisions as a good sign for the company’s business outlook.

Research indicates that these estimate revisions are directly correlated with near-term share price momentum. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.

The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 110% higher. CRON is currently sporting a Zacks Rank of #5 (Strong Sell).

Investors should also note CRON’s current valuation metrics, including its Forward P/E ratio of 176. This valuation marks a premium compared to its industry’s average Forward P/E of 10.25.

The Financial – Investment Management industry is part of the Finance sector. This group has a Zacks Industry Rank of 238, putting it in the bottom 8% of all 250+ industries.

The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Cronos Group institutional ownership is held at 15.45% while insider ownership was 5.40%. Its EPS was $-0.03 while outstanding shares of the company were 178.71 million. The Company’s Net profit margin was 0.00% while gross profit margin was 0.00%. CRON last month stock price volatility remained 8.57%.

The stock is now trading at a distance of 53.92% from 20-day simple moving average. The company’s price sits 89.62% above from its 50-day moving average of $13.49 and 156.86% far from the stock’s 200-day moving average which is $10.20.

Cronos Group Inc. (NASDAQ:CRON) currently has a PEG ratio of 0.00 where as its P/E ratio is 0.00. The company’s price to sales ratio for trailing twelve months is 0.00 and price to book ratio for most recent quarter is 24.89, whereas price to cash per share for the most recent quarter is 0.00. Cronos Group Inc. (NASDAQ:CRON)’s price to free cash flow for trailing twelve months is 0.00. Its quick ratio for most recent quarter is 0.00 along with current ratio for most recent quarter of 0.00. Total debt to equity ratio of the company for most recent quarter is 0.00 whereas long term debt to equity ratio for most recent quarter is 0.00. Cronos Group Inc. (NASDAQ:CRON) has a Return on Assets of 0.00%. The company currently has a Return on Equity of 0.00% and Return on Investment of 0.00%.

Amber Dunlea

My Self Amber Dunlea and I’m working in the industry of financial news developer and adviser, performing my duties for over 5 years in the industry, stared my work as a adviser, working experience with the seniors I become the major adviser and financial news reporter behind “stocks news point” with a vision to increase the benefits in the shape or profit and by introducing new customers, I personally like to show my interest in the business development and adviser, now I am the major news reporter/adviser in the sector of " Healthcare & Biotech " companies.